Kim Wang-Soo, Cho Young, Kim Jee-Cheon, Huang Zai-Zhi, Park Sun-Hee, Choi Ehn-Kyoung, Shin Sunhee, Nam Sang-Yoon, Kang Jong-Koo, Hwang Seock-Yeon, Kim Yun-Bae
Biomedical Section, Agency for Defense Development, Yuseong P.O. Box 35-1, Daejeon 305-600, Republic of Korea.
Eur J Pharmacol. 2005 Nov 21;525(1-3):135-42. doi: 10.1016/j.ejphar.2005.09.052. Epub 2005 Oct 27.
The prophylactic efficacy of a combinational patch system containing physostigmine and procyclidine against soman intoxication was evaluated using dogs. Female beagle dogs (body weights 9-10 kg) were shaved on the abdominal side, attached with a matrix-type patch (7x7 cm) containing 1.5% of physostigmine plus 6% procyclidine for 2 days, and challenged with subcutaneous injection of serial doses (2-10 LD50) of soman. Separately, in combination with the patch attachment, atropine (2 mg/dog) plus 2-pralidoxime (600 mg/dog) or atropine plus 1-[([4-(aminocarbonyl)pyridinio]methoxy)methyl]-2-[(hydroxyimino)methyl]pyridinium (HI-6, 500 mg/dog) were injected intramuscularly 1 min after soman poisoning. The LD50 value of soman was determined to be 9.1 microg/kg, and high doses (> or = 1.4 LD50) of soman induced salivation, emesis, defecation and diarrhea, tremors and seizures, and recumbency of dogs, leading to 100% mortality in 24 h. The prophylactic patch, which led to mean 18.5-18.8% inhibition of blood cholinesterase activity by physostigmine and mean 7.9-8.3 ng/ml of blood concentration of procyclidine, exerted a high protection ratio (4.7 LD50), in comparison with relatively-low effects of traditional antidotes, atropine plus 2-pralidoxime (2.5 LD50) and atropine plus HI-6 (2.7 LD50). Noteworthy, a synergistic increase in the protection ratio was achieved by the combination of the patch with atropine plus HI-6 (9 LD50), but not with atropine plus 2-pralidoxime (5 LD50). In addition, the patch system markedly attenuated the cholinergic signs and seizures induced by soman, especially when combined with atropine plus HI-6, leading to elimination of brain injuries and physical incapacitation up to 6 LD50 of soman poisoning. Taken together, it is suggested that the patch system containing physostigmine and procyclidine, especially in combination with atropine and HI-6, could be a choice for the quality survival from nerve-agent poisoning.
使用犬类评估了一种含有毒扁豆碱和丙环定的组合贴片系统对梭曼中毒的预防效果。雌性比格犬(体重9 - 10千克)腹部剃毛,贴上含1.5%毒扁豆碱加6%丙环定的基质型贴片(7×7厘米),持续2天,然后皮下注射连续剂量(2 - 10倍半数致死量)的梭曼进行挑战。另外,在贴贴片的同时,梭曼中毒1分钟后肌肉注射阿托品(2毫克/犬)加2 - 解磷定(600毫克/犬)或阿托品加1 - [([4 - (氨基羰基)吡啶鎓]甲氧基)甲基]-2 - [(羟基亚氨基)甲基]吡啶鎓(HI - 6,500毫克/犬)。梭曼的半数致死量值确定为9.1微克/千克,高剂量(≥1.4倍半数致死量)的梭曼可引起犬类流涎、呕吐、排便和腹泻、震颤和惊厥以及卧倒,导致24小时内100%死亡。该预防贴片使毒扁豆碱对血液胆碱酯酶活性的平均抑制率为18.5 - 18.8%,丙环定的血液浓度平均为7.9 - 8.3纳克/毫升,与传统解毒剂阿托品加2 - 解磷定(2.5倍半数致死量)和阿托品加HI - 6(2.7倍半数致死量)相对较低的效果相比,具有较高的保护率(4.7倍半数致死量)。值得注意的是,贴片与阿托品加HI - 6联合使用(9倍半数致死量)可使保护率协同增加,但与阿托品加2 - 解磷定联合使用(5倍半数致死量)则不然。此外,该贴片系统显著减轻了梭曼引起的胆碱能症状和惊厥,特别是与阿托品加HI - 6联合使用时,可消除高达6倍半数致死量梭曼中毒所致的脑损伤和身体机能丧失。综上所述,含有毒扁豆碱和丙环定的贴片系统,尤其是与阿托品和HI - 6联合使用时,可能是从神经毒剂中毒中高质量存活的一种选择。
Eur J Pharmacol. 2005-11-21
Eur J Pharmacol. 2004-11-28
Toxicol Appl Pharmacol. 2004-5-1
Toxicol Appl Pharmacol. 2007-4-15
J Pharmacol Exp Ther. 1993-3
Front Vet Sci. 2023-3-2
Eur J Drug Metab Pharmacokinet. 2016-6